Assessing Repeat Fit Testing for CRC

Colo-rectal Cancer Clinical Trial

— ARFT  

Official title:

Assessing Repeat Annual FIT Screening for Colo-Rectal Cancer (CRC)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03248661
• Other study ID #: 14-0662-P3H
• Status: Completed
• Phase: Phase 3
• Start date: August 1, 2015
• Est. completion date: September 25, 2018

Study information

• Verified date: January 2019
• Source: University of Kentucky
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will randomly assign 220 men and women to either a social media intervention or a standard reminder system to have a repeat screening test for colo-rectal cancer.

Description:

Only persons initially screening by FIT (through a Rural Cancer Prevention Center service program) will be eligible for study participation. The objective is to test a social media-based intervention designed to promote annual repeat colo-rectal cancer screening using the Fecal Immunochemical Test (FIT) among person who have taken the FIT test once before. 220 men and women (50 to 75 years of age) will be recruited and randomly assigned to either the intervention condition (monthly social media contact) or a control condition (standard of care reminder for repeat testing one month before the annual test is due). The dependent variable will be whether volunteers requested and retuned a FIT kit with 60 days of the annual due date (one year from their initial screening).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 220
• Est. completion date: September 25, 2018
• Est. primary completion date: September 25, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 30 Years to 75 Years

Eligibility

Inclusion Criteria:

• must have completed and returned an initial FIT kit to us as part of a Rural Cancer Prevention Center service program to the community

Exclusion Criteria:

• visible blood in stool or prior diagnosis of cool-rectal cancer

Related Conditions & MeSH terms

• Colo-rectal Cancer
• Colorectal Neoplasms
• Rectal Neoplasms

Intervention

Behavioral:
• Now I'm Telling You
Messages will be sent trough Facebook, Twitter, Instagram, e-mail, texting or other electronic/social media specified by study volunteers.

Locations

Country	Name	City	State
United States	University of Kentucky	Lexington	Kentucky

Sponsors (2)

Lead Sponsor	Collaborator
Richard Crosby	Centers for Disease Control and Prevention

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Primary endpoint is a received completed FIT kit within 15 months after the participant received results from the original FIT test	the endpoint is a received completed FIT kit	15 months